- Tofacitinib 11mg modified-release tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Tofacitinib 11mg modified-release tablets | Start Date 21-02-2020 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Modified-release tablet
- Ontology Form/Route
- tabletmodified-release.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L04AF01
- BNF Codes
-
- BNF code 10010300
Code | Start Date | End Date |
---|---|---|
38162311000001103 | 21-02-2020 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Tofacitinib citrate | Based on Base Substance | Tofacitinib | 11 mg |
Name
Tofacitinib citrate
Basis of strength description
Based on Base Substance
BOSS
Tofacitinib
Strength and UOM (Nmr)
11
Strength and UOM (Dmr)
Parent Products
-
VTMTofacitinib
-
VMP(Current) Tofacitinib 11mg modified-release ta...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
28 tablet |